These rankings are based on data from September 2026
Company
Pathos
Years in business
- 4
Number of employees
- 11-50 employees
Country
- United States
Pathos leverages AI to optimize drug development, focusing on patient selection, biomarker development, and trial design to accelerate precision medicine delivery.
API Availability
- Unknown
Pricing
unknown
Ranking position over time
October 2025 - September 2026
#663
Best rank
#1,240
Lowest rank
Down 71 spots over 12 months
12-month trend
#9,312
Best rank
#18,229
Lowest rank
Down 2,530 spots over 12 months
12-month trend
#187
Best rank
#357
Lowest rank
Down 170 spots over 12 months
12-month trend
Position of Pathos on sub rankings
September 2026
Industries
health & sports
L3 category names
Company
Pathos
Years in business
- 4
Number of employees
- 11-50 employees
Country
- United States
Popular tools
Popular rankings
Latest insights
- OpenAI’s new business feature: a death blow to AI visibility trackers?
- AI Product Image Generators: The Most Popular Solutions Reshaping E-Commerce Visuals
- 5 New AI Tools: From the dentist's front desk to the law firm's intake
- Persona Development: The Most Popular AI Tools for Building Your Ideal Customer
- Behind the scenes: Better search, ranking history and faster tool listings
Insights
AI Product Image Generators: The Most Popular Solutions Reshaping E-Commerce Visuals
AI is finding increasingly concrete applications in marketing, but the number of tools is growing so fast that keeping track is becoming a challenge. In this recurring series, RankmyAI spotlights an AI application relevant to marketers every two weeks.
OpenAI’s new business feature: a death blow to AI visibility trackers?
OpenAI’s new Business Hub gives companies statistics based on actual ChatGPT use, reducing the added value of paid AI visibility trackers. Referral traffic data and the difficulty of reproducing personalised recommendations raise further questions about what businesses gain from these services.
